
-
Djokovic crashes to nervous Arnaldi in Madrid opener
-
Syria's Kurds demand 'democratic decentralised' Syria
-
Leverkusen win to delay Bayern and Kane's title party
-
Buenos Aires farewells native pontiff with tears and calls to action
-
Turkey's opposition says Erdogan's canal plan behind latest arrests
-
Maresca hails 'nasty' Chelsea as top five bid stays alive
-
Trump raises Putin doubts after Zelensky talks at pope's funeral
-
Major blast at Iran port kills 4, injures hundreds
-
Napoleon's sword to be sold at auction in Paris
-
Iran, US discuss nuclear deal in third round of talks
-
Buenos Aires farewells native pontiff with call to action
-
Warholm sets hurdles world record at Diamond League, Holloway shocked
-
US students 'race' sperm in reproductive health stunt
-
Wikileaks founder Assange joins crowds for pope funeral
-
Leader Marc Marquez claims Spanish MotoGP sprint victory
-
Celtic win fourth successive Scottish Premiership title
-
Jackson ends drought as Chelsea boost top five push
-
Warholm sets 300m hurdles world record in Diamond League opener
-
Major blast at south Iran port kills 4, injures hundreds
-
Russia says retook Kursk from Ukraine with North Korean help
-
Francis laid to rest as 400,000 mourn pope 'with an open heart'
-
Trump, Zelensky meet on sidelines of pope's funeral
-
'Shared loss': Filipino Catholics bid Pope Francis farewell
-
Families unable to reunite as India-Pakistan border slams shut
-
Major blast at south Iran port injures hundreds
-
Foreign carmakers strive for 'China Speed' to stay in race
-
Pakistan says open to neutral probe into Kashmir attack after India threats
-
Hundreds of thousands at funeral mourn pope 'with an open heart'
-
Quartararo sets Spanish MotoGP record to claim pole
-
Hamas says open to 5-year Gaza truce, one-time hostages release
-
Iran, US hold new round of high-stakes nuclear talks
-
Up at dawn for front-row seat to history at Francis's funeral
-
Pakistan ready to 'defend sovereignty' after India threats
-
Huge crowds flock to Vatican for Pope Francis's funeral
-
Xi says China must 'overcome' AI chip challenges
-
Indian army says new exchange of gunfire with Pakistan
-
Epstein accuser Virginia Giuffre takes own life in Australia: family
-
Hundreds of buildings damaged, dozens injured in 6.3 Ecuador quake
-
India and Pakistan's Kashmir fallout hits economy too
-
Francis's funeral to be grand farewell to 'pope of the poor'
-
Pogacar faces defiant Evenepoel at Liege-Bastogne-Liege
-
Chelsea eye great escape against Barcelona in Women's Champions League
-
Iran, US to hold new round of high-level nuclear talks
-
'Energy and effort' pay off for Reds as Blues' woes continue
-
Albatross and closing birdie lift China's Liu to LPGA Chevron lead
-
On the horizon? Wave of momentum for high seas treaty
-
New to The Street Launches For The Causes(TM) Monthly Awareness Segments: Offering Free National Media to Charities and Organizations
-
Top Mistakes to Avoid When Building Credit History
-
Developing countries should fast-track US trade deals: World Bank president
-
Grizzlies' Morant 'doubtful' for must-win game 4 v Thunder

From Covid to cancer: High hopes for Nobel mRNA vaccines
The coronavirus pandemic brought global renown to the mRNA technology that underpins vaccines from Pfizer/BioNTech and Moderna, and on Monday earned a Nobel Prize for two scientists who have been key to its development.
Katalin Kariko of Hungary and Drew Weissman of the United States won the Nobel Medicine Prize for their work on "nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19".
These types of jabs are new but researchers have been working for decades to try to figure out how to use messenger RNA (ribonucleic acid) for other vaccinations and to treat illnesses from AIDS to cancer.
- How does it work? -
Messenger RNA's job in the body is to help deliver specific instructions from DNA to cells.
In the case of the Pfizer/BioNTech and Moderna jabs, lab-generated mRNA tells human cells to create antigens -- proteins that are similar to ones found in the Covid-19 virus.
Thanks to those antigens, a person's immune system learns how to fight the virus and neutralise Covid if it enters the body.
After the cells create these proteins, the body breaks down the mRNA instructions and gets rid of them.
Such direct communication with cells is revolutionary -- classic vaccines aimed to provoke an immune response by injecting a neutralised form of a virus or antigens into the system.
- Where did this come from? -
The first big breakthrough, in the late 1970s, was in using mRNA to make test-tube cells produce proteins.
A decade later, scientists were able to get the same results in mice, but mRNA still had two major drawbacks as a medical tool.
For one thing, cells in live animals resisted synthetic mRNA, provoking a dangerous immune response.
On top of that, mRNA molecules are fragile, making them difficult to deliver to the system without altering them.
In 2005, Kariko and Weissman of Penn State University published a groundbreaking study showing that a lipid -- or fat molecule -- envelope could safely deliver mRNA without negative effects.
The research caused a buzz in the pharmaceutical community and start-ups dedicated to mRNA therapies began to pop up around the world.
- What else can mRNA do? -
Scientists have worked on developing mRNA jabs for illnesses like seasonal flu, rabies and Zika, as well as those that have remained vaccine-resistant until now, including malaria and AIDS.
Researchers have also started testing personalised treatments on cancer patients, using samples of the proteins in their tumours to create specialised mRNA.
This then triggers the immune system to target specific cancer cells.
"The mRNA platform is versatile," University of Pennsylvania biochemist Norbert Pardi told AFP. "Any protein can be encoded as mRNA so there are many potential applications."
G.Stevens--AMWN